The effect of formoterol on the late asthmatic phenomena in guinea pigs

Haruhito Sugiyama, Chiharu Okada, Againdra K. Bewtra, Russell J. Hopp, Robert G. Townley

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

We investigated the effects of formoterol, a new, long-acting, selective β2-adrenoceptor agonist, on the antigen-induced late asthmatic response (LAR) and airway inflammation in guinea pigs. Animals were sensitized by exposure to aerosolized ovalbumin (2% in saline). After antigen challenge, preceded by administration of an H1-receptor antagonist, specific airway conductance was measured with a two-chambered whole-body plethysmograph. An aerosolized solution of formoterol, isoproterenol, or saline was inhaled 15 minutes before challenge. Bronchoalveolar lavage (BAL) was performed 24 hours after challenge. The provocative concentrations of histamine required to decrease specific airway conductance by 50% were obtained before challenge, at 24 hours, and at 72 hours after challenge. The LAR (52.7% ± 7.7% of the baseline; p <0.02) was observed 6 to 8 hours after antigen challenge. An increased cellular influx in BAL (mainly eosinophils and macrophages) and an increased bronchial responsiveness to histamine occurred 24 hours after antigen challenge. Formoterol completely inhibited the LAR and the cellular increase in BAL; however, isoproterenol failed to prevent either the cellular infiltration or the LAR. Formoterol also decreased the antigen-induced increase in bronchial reactivity. These findings suggest that formoterol has inhibitory effects on the underlying inflammatory processes in antigen-induced asthma in addition to prolonged bronchodilation.

Original languageEnglish
Pages (from-to)858-866
Number of pages9
JournalJournal of Allergy and Clinical Immunology
Volume89
Issue number4
DOIs
StatePublished - 1992

Fingerprint

Guinea Pigs
Antigens
Bronchoalveolar Lavage
Isoproterenol
Histamine
Histamine H1 Receptors
Ovalbumin
Eosinophils
Adrenergic Receptors
Formoterol Fumarate
Asthma
Macrophages
Inflammation

All Science Journal Classification (ASJC) codes

  • Immunology
  • Immunology and Allergy

Cite this

The effect of formoterol on the late asthmatic phenomena in guinea pigs. / Sugiyama, Haruhito; Okada, Chiharu; Bewtra, Againdra K.; Hopp, Russell J.; Townley, Robert G.

In: Journal of Allergy and Clinical Immunology, Vol. 89, No. 4, 1992, p. 858-866.

Research output: Contribution to journalArticle

Sugiyama, Haruhito ; Okada, Chiharu ; Bewtra, Againdra K. ; Hopp, Russell J. ; Townley, Robert G. / The effect of formoterol on the late asthmatic phenomena in guinea pigs. In: Journal of Allergy and Clinical Immunology. 1992 ; Vol. 89, No. 4. pp. 858-866.
@article{244ac39c6ce543e09028b6d07c8e42fd,
title = "The effect of formoterol on the late asthmatic phenomena in guinea pigs",
abstract = "We investigated the effects of formoterol, a new, long-acting, selective β2-adrenoceptor agonist, on the antigen-induced late asthmatic response (LAR) and airway inflammation in guinea pigs. Animals were sensitized by exposure to aerosolized ovalbumin (2{\%} in saline). After antigen challenge, preceded by administration of an H1-receptor antagonist, specific airway conductance was measured with a two-chambered whole-body plethysmograph. An aerosolized solution of formoterol, isoproterenol, or saline was inhaled 15 minutes before challenge. Bronchoalveolar lavage (BAL) was performed 24 hours after challenge. The provocative concentrations of histamine required to decrease specific airway conductance by 50{\%} were obtained before challenge, at 24 hours, and at 72 hours after challenge. The LAR (52.7{\%} ± 7.7{\%} of the baseline; p <0.02) was observed 6 to 8 hours after antigen challenge. An increased cellular influx in BAL (mainly eosinophils and macrophages) and an increased bronchial responsiveness to histamine occurred 24 hours after antigen challenge. Formoterol completely inhibited the LAR and the cellular increase in BAL; however, isoproterenol failed to prevent either the cellular infiltration or the LAR. Formoterol also decreased the antigen-induced increase in bronchial reactivity. These findings suggest that formoterol has inhibitory effects on the underlying inflammatory processes in antigen-induced asthma in addition to prolonged bronchodilation.",
author = "Haruhito Sugiyama and Chiharu Okada and Bewtra, {Againdra K.} and Hopp, {Russell J.} and Townley, {Robert G.}",
year = "1992",
doi = "10.1016/0091-6749(92)90442-5",
language = "English",
volume = "89",
pages = "858--866",
journal = "Journal of Allergy and Clinical Immunology",
issn = "0091-6749",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - The effect of formoterol on the late asthmatic phenomena in guinea pigs

AU - Sugiyama, Haruhito

AU - Okada, Chiharu

AU - Bewtra, Againdra K.

AU - Hopp, Russell J.

AU - Townley, Robert G.

PY - 1992

Y1 - 1992

N2 - We investigated the effects of formoterol, a new, long-acting, selective β2-adrenoceptor agonist, on the antigen-induced late asthmatic response (LAR) and airway inflammation in guinea pigs. Animals were sensitized by exposure to aerosolized ovalbumin (2% in saline). After antigen challenge, preceded by administration of an H1-receptor antagonist, specific airway conductance was measured with a two-chambered whole-body plethysmograph. An aerosolized solution of formoterol, isoproterenol, or saline was inhaled 15 minutes before challenge. Bronchoalveolar lavage (BAL) was performed 24 hours after challenge. The provocative concentrations of histamine required to decrease specific airway conductance by 50% were obtained before challenge, at 24 hours, and at 72 hours after challenge. The LAR (52.7% ± 7.7% of the baseline; p <0.02) was observed 6 to 8 hours after antigen challenge. An increased cellular influx in BAL (mainly eosinophils and macrophages) and an increased bronchial responsiveness to histamine occurred 24 hours after antigen challenge. Formoterol completely inhibited the LAR and the cellular increase in BAL; however, isoproterenol failed to prevent either the cellular infiltration or the LAR. Formoterol also decreased the antigen-induced increase in bronchial reactivity. These findings suggest that formoterol has inhibitory effects on the underlying inflammatory processes in antigen-induced asthma in addition to prolonged bronchodilation.

AB - We investigated the effects of formoterol, a new, long-acting, selective β2-adrenoceptor agonist, on the antigen-induced late asthmatic response (LAR) and airway inflammation in guinea pigs. Animals were sensitized by exposure to aerosolized ovalbumin (2% in saline). After antigen challenge, preceded by administration of an H1-receptor antagonist, specific airway conductance was measured with a two-chambered whole-body plethysmograph. An aerosolized solution of formoterol, isoproterenol, or saline was inhaled 15 minutes before challenge. Bronchoalveolar lavage (BAL) was performed 24 hours after challenge. The provocative concentrations of histamine required to decrease specific airway conductance by 50% were obtained before challenge, at 24 hours, and at 72 hours after challenge. The LAR (52.7% ± 7.7% of the baseline; p <0.02) was observed 6 to 8 hours after antigen challenge. An increased cellular influx in BAL (mainly eosinophils and macrophages) and an increased bronchial responsiveness to histamine occurred 24 hours after antigen challenge. Formoterol completely inhibited the LAR and the cellular increase in BAL; however, isoproterenol failed to prevent either the cellular infiltration or the LAR. Formoterol also decreased the antigen-induced increase in bronchial reactivity. These findings suggest that formoterol has inhibitory effects on the underlying inflammatory processes in antigen-induced asthma in addition to prolonged bronchodilation.

UR - http://www.scopus.com/inward/record.url?scp=0026554705&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026554705&partnerID=8YFLogxK

U2 - 10.1016/0091-6749(92)90442-5

DO - 10.1016/0091-6749(92)90442-5

M3 - Article

C2 - 1348516

AN - SCOPUS:0026554705

VL - 89

SP - 858

EP - 866

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

SN - 0091-6749

IS - 4

ER -